Apollon Wealth Management, LLC Invitae Corp Transaction History

Apollon Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$1.05 - $1.63 $148 - $229	-141 Reduced 0.63%	22,245 $25,000
Q4 2022 Feb 15, 2023	SELL	$1.71 - $3.61 $51 - $108	-30 Reduced 0.13%	22,386 $41,000
Q3 2022 Nov 08, 2022	BUY	$1.9 - $8.63 $42,590 - $193,450	22,416 New	22,416 $55,000
Q3 2020 Nov 03, 2020	SELL	$28.43 - $44.67 $4,690 - $7,370	-165 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $1,932 - $4,997	165 New	165 $5,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Apollon Wealth Management, LLC with notifications on news.